Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FTO-genotype dependent weight reduction with bromocriptine in obese patients
2011-005628-16Phase 2Completed
- Sponsor
- University of Cologne
- Start
- May 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of bromocriptine in obesity, sponsored by University of Cologne. Primary endpoint: Body mass index. Started May 2012; status: completed.
02
Drugs
bromocriptine
03
Conditions
obesity
Beyond the preview
Go deeper on 2011-005628-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005628-16.